Skip to main content

Published locations for FDA: Benefits still outweigh risks from paclitaxel-coated devices for PAD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA: Benefits still outweigh risks from paclitaxel-coated devices for PAD

User login

  • Reset your password
  • /content/fda-benefits-still-outweigh-risks-paclitaxel-coated-devices-pad-0
  • /familypracticenews/article/193264/lipid-disorders/fda-benefits-still-outweigh-risks-paclitaxel
  • /internalmedicinenews/article/193264/lipid-disorders/fda-benefits-still-outweigh-risks-paclitaxel
  • /clinicalendocrinologynews/article/193264/lipid-disorders/fda-benefits-still-outweigh-risks
  • /ecardiologynews/article/193264/lipid-disorders/fda-benefits-still-outweigh-risks-paclitaxel-coated
  • /cardiology/article/193264/lipid-disorders/fda-benefits-still-outweigh-risks-paclitaxel-coated
  • /endocrinology/article/193264/lipid-disorders/fda-benefits-still-outweigh-risks-paclitaxel-coated
  • /internalmedicine/article/193264/lipid-disorders/fda-benefits-still-outweigh-risks-paclitaxel-coated
  • /familymedicine/article/193264/lipid-disorders/fda-benefits-still-outweigh-risks-paclitaxel-coated